SCHEMBL14633350

SCHEMBL14633350

O=c1c2cnc(Nc3ccc(N4CCNCC4)cc3)nc2c(C2CCC2)nn1-c1c(Cl)cccc1Cl

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ WEE1 P30291 10/20 0.59
▸ CDK4 P11802 10/20 0.52
▸ CCND1 P24385 10/20 0.52
▸ CYP3A4 P08684 1/20 0.51
▸ CCND2 P30279 6/20 0.51
▸ CCND3 P30281 6/20 0.51
▸ CCNE1 P24864 5/20 0.51
▸ CDK2 P24941 5/20 0.51
▸ CCNE2 O96020 3/20 0.51
▸ CCNA2 P20248 3/20 0.51
▸ CCNA1 P78396 3/20 0.51
▸ CDK1 P06493 4/20 0.50
▸ CCNB1 P14635 4/20 0.50
▸ FGFR1 P11362 2/20 0.48
▸ FGFR2 P21802 2/20 0.48
▸ FGFR4 P22455 2/20 0.48
▸ FGFR3 P22607 2/20 0.48
▸ NUAK1 O60285 1/20 0.48
▸ CCNB2 O95067 2/20 0.47
▸ CCNB3 Q8WWL7 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14633553 0.97 WEE1 (0.61) WEE1CDK4CCND1CYP3A4CCND2
SCHEMBL14633394 0.90 WEE1 (0.64) WEE1CYP3A4FGFR1FGFR2FGFR4
SCHEMBL14633436 0.90 WEE1 (0.61) WEE1CYP3A4FGFR1FGFR2FGFR4
SCHEMBL14633155 0.89 WEE1 (0.64) WEE1CYP3A4FGFR1FGFR2FGFR4
SCHEMBL14633004 0.87 WEE1 (0.58) WEE1CYP3A4FGFR1FGFR2FGFR4
SCHEMBL14633386 0.87 WEE1 (0.66) WEE1CYP3A4FGFR1FGFR2FGFR4
SCHEMBL14633331 0.86 WEE1 (0.63) WEE1CDK4CCND1CYP3A4CCND2
SCHEMBL14633173 0.84 WEE1 (0.61) WEE1CDK4CCND1CYP3A4CCND2
SCHEMBL14633493 0.84 WEE1 (0.61) WEE1CDK4CCND1CYP3A4CCND2
SCHEMBL14633052 0.84 WEE1 (0.61) WEE1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796289-B2 Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases ABBVIE INC. (US) 2014-08-05 — — US claimed
WO-2013013031-A1 PYRIDAZINO [4, 5 -D] PYRIMIDIN- (6H) -ONE INHIBITORS OF WEE - 1 KINASE ABBVIE INC. (US) 2013-01-24 — — WO claimed
US-20130023523-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES ABBOTT LABORATORIES (US) 2013-01-24 — — US claimed
US-9051327-B2 Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases ABBVIE INC. (US) 2015-06-09 — — US disclosed
US-20140296220-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES ABBVIE INC (US) 2014-10-02 — — US disclosed
US-8796289-B2 Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases ABBVIE INC. (US) 2014-08-05 — — US disclosed
WO-2013013031-A1 PYRIDAZINO [4, 5 -D] PYRIMIDIN- (6H) -ONE INHIBITORS OF WEE - 1 KINASE ABBVIE INC. (US) 2013-01-24 — — WO disclosed
US-20130023523-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES ABBOTT LABORATORIES (US) 2013-01-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296220-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES WEE1, WEE2, CDK1 WEE1 1/4885CDK4 31/4885CCND1 291/4885
US-20130023523-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES WEE1, WEE2, CDK1 WEE1 1/4885CDK4 31/4885CCND1 291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback